Moderna Inc (MRNA)vsNutriband Inc (NTRB)
MRNA
Moderna Inc
$143.97
+5.38%
HEALTHCARE · Cap: $56.02B
NTRB
Nutriband Inc
$6.96
+14.47%
HEALTHCARE · Cap: $72.57M
Smart Verdict
WallStSmart Research — data-driven comparison
Moderna Inc generates 123499% more annual revenue ($2.23B vs $1.80M). NTRB leads profitability with a 0.0% profit margin vs -141.4%. MRNA earns a higher WallStSmart Score of 21/100 (F).
MRNA
Avoid21
out of 100
Grade: F
NTRB
Avoid13
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+70.0%
Fair Value
$134.97
Current Price
$143.97
$9.00 discount
Intrinsic value data unavailable for NTRB.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Conservative balance sheet, low leverage
Conservative balance sheet, low leverage
Areas to Watch
Trading at 8.5x book value
2.1% revenue growth
Weak financial health signals
ROE of -46.6% — below average capital efficiency
Trading at 14.2x book value
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : MRNA
The strongest argument for MRNA centers on Market Cap, Debt/Equity.
Bull Case : NTRB
The strongest argument for NTRB centers on Debt/Equity.
Bear Case : MRNA
The primary concerns for MRNA are Price/Book, Revenue Growth, Piotroski F-Score.
Bear Case : NTRB
The primary concerns for NTRB are Price/Book, EPS Growth, Market Cap.
Key Dynamics to Monitor
MRNA profiles as a turnaround stock while NTRB is a value play — different risk/reward profiles.
NTRB carries more volatility with a beta of 2.04 — expect wider price swings.
MRNA is growing revenue faster at 2.1% — sustainability is the question.
NTRB generates stronger free cash flow (-585,003), providing more financial flexibility.
Bottom Line
MRNA scores higher overall (21/100 vs 13/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Moderna Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.
Nutriband Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Nutriband Inc. develops a portfolio of transdermal pharmaceuticals. The company is headquartered in Orlando, Florida.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?